Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway

Esther Diaz-Rodriguez1, Angela R Garcia-Rendueles, Alejandro Ibáñez-Costa

  • 1Centre for Investigations in Medicine of the USC (E.D.-R., A.R.G.-G., M.G.-L., C.D., C.V.A.), University of Santiago de Compostela, Santiago de Compostela, Spain 15782; Department of Endocrinology (I.B.), University Hospital (University Hospital of Santiago de Compostela), Instituto de Investigación Sanitaria, Santiago de Compostela, Spain 15706; Departments of Cell Biology, Physiology, and Immunology (A.I.-C., E.G.-P., R.M.L., J.P.C.), and Morphological Sciences (L.J.-R.), University of Cordoba, and Reina Sofia University Hospital (P.B., M.A.G.), Maimonides Institute for Research in Biomedicine of Cordoba, Córdoba, Spain 14014; Departments of Endocrinology and Pathology (A.L., M.A.J., A.S., E.V.), Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, University of Sevilla, Sevilla, Spain 41013; Department of Endocrinology (F.J.T.), Hospital Virgen de la Victoria, and Department of Endocrinology (J.A.G.-A.), Hospital Carlos Haya, Malaga, Spain 29010; and CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn) 15706, spain (A.I.-C., F.J.T., P.B., I.B., C.D., R.M.L., J.P.C., C.V.A.), Spain 15706.

Endocrinology
|August 20, 2014
PubMed

Insights

Acromegaly adenomas (ACROs) utilize a RET/Pit1/p14ARF/p53 pathway for apoptosis, which Glial Cell Derived Neurotrophic Factor (GDNF) inhibits. Targeting GDNF

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Acromegaly results from somatotroph cell adenomas (ACROs) secreting growth hormone (GH).
  • Rodent studies reveal a RET/Glial Cell Derived Neurotrophic Factor (GDNF) pathway influencing apoptosis via Pit1 and p53.
  • The role of this pathway in human ACROs remains unclear.

Purpose of the Study:

  • To investigate the presence and function of the RET/Pit1/p14ARF/p53/apoptosis pathway in human ACROs compared to nonfunctioning pituitary adenomas (NFPAs).
  • To determine the effect of GDNF on this pathway in ACROs.

Main Methods:

  • Primary cell cultures of human ACROs and NFPAs were treated with and without GDNF.
  • Apoptosis levels were assessed.
  • Protein expression of RET, Pit1, p19Arf, p53, and phospho-Akt was analyzed using Western blotting and qRT-PCR.

Main Results:

  • ACROs, but not NFPAs, exhibited significant apoptosis when deprived of GDNF, which GDNF prevented.
  • This apoptosis was linked to RET processing, Pit1 accumulation, and p14ARF/p53 induction, inhibited by GDNF via phospho-Akt activation.
  • Overexpression of human Pit1 induced apoptosis in a pituitary cell line, and GDNF expression correlated with RET and inversely with p53 in tumors.

Conclusions:

  • Human ACROs possess an active RET/Pit1/p14ARF/p53/apoptosis pathway.
  • GDNF inhibits this pathway, promoting ACRO cell survival.
  • Disrupting GDNF's survival function presents a potential therapeutic strategy for acromegaly.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K